Guizhou Bailing Group Pharmaceutical Co., Ltd.

SZSE:002424.SZ

7.99 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20232022202120202019201820172016201520142013201220112010200920082007
Operating Activities:
Net Income -412.464135.971116.688153.726293.186571.767532.03486.262416.149315.054272.994228.859209.98158.198111.66780.29671.997
Depreciation & Amortization 116.659116.164107.01196.48388.60280.14273.4274.56170.86563.98148.26644.87228.25213.74813.51413.19112.399
Deferred Income Tax -111.494-12.458-3.098-15.055-4.956-8.957-4.604-4.159-9.200000000
Stock Based Compensation 00000000000000000
Change In Working Capital 191.61233.49617.499-237.054-125.31-870.786-570.757-133.284-130.317-22.355-223.819-307.656-91.213-649.1086.786-150.715-165.179
Accounts Receivables -34.965-182.702193.729-163.736145.332-829.239-510.38-16.76-122.829-229.491-202.66-123.89100000
Inventory -396.588.735-63.225221.061-146.081-24.055-147.553-53.77968.4847.502-77.771-66.897-256.493-254.2499.50110.265-45.306
Accounts Payables 734.65219.921-95.76633.306-111.931-8.53591.78-58.586-66.77200000000
Other Working Capital 0-12.458-17.238-327.685-12.63-846.731-423.204-79.506-198.801-29.857-146.048-240.759165.28-394.859-2.715-160.98-119.873
Other Non Cash Items 94.431216.52183.723218.625210.93661.4345.19139.07756.53239.15344.31553.4454.88529.484-6.65916.8061.41
Operating Cash Flow 125.767502.152324.922231.78467.414-157.44579.884466.615413.229395.833141.75619.516201.903-447.678125.308-40.423-79.374
Investing Activities:
Investments In Property Plant And Equipment -104.118-68.452-425.727-90.024-121.906-129.014-144.683-159.336-121.044-96.491-88.745-180.159-193.073-165.691-21.914-12.913-5.676
Acquisitions Net -3.91700.123-31.396-0129.2384.78911.1120.045-0.480.202-9.649-134.121000.11520.822
Purchases Of Investments 0-14.7-860.153-465.115-732.593-8000-100-1010-16000-5.8340
Sales Maturities Of Investments 25.04561.97617.80712.2120.332.122.123.028106.974110.3923.1210161.55500.420.63.3
Other Investing Activites 46.741.615536.382-95.68952.19-129.0142.7244.0262.39527.2047.295-180.1590-165.691-4.927106.14152.981
Investing Cash Flow -34.83120.43942.585-204.744-534.501-859.264-215.05-152.282-11.675-59.376-179.127-189.808-325.639-165.691-26.42188.1171.427
Financing Activities:
Debt Repayment -15.981-1,662.1-2,182.1-2,360.1-1,581.6-861.6-974-796.6-751.6-1,010.6-889.4-565.4-570.4-280.6-217.2-237.4-250.9
Common Stock Issued 00100.2000011000000000
Common Stock Repurchased -100.0060-100.20000835.6000000000
Dividends Paid -80.542-86.551-100.184-310.464-112.896-157.886-148.165-146.596-137.528-146.797-247.558-157.469-180.819-82.738-9.57-9.736-11.498
Other Financing Activities -150.2481,433.3721,515.892,380.3042,420.61,581.61,040.08538.862786.579762.403953.691738.741655.1782,105.683281.192222.4194.02
Financing Cash Flow -214.809-315.279-766.394-411.367624.208562.114-82.081-57.734-102.55-394.994-183.26715.871-96.0411,742.34454.422-24.736-68.378
Other Information:
Effect Of Forex Changes On Cash -00-00-0.005000000-000000
Net Change In Cash -123.874207.313-398.887-384.331557.115-454.595-217.246256.599299.004-58.537-220.638-154.421-219.7771,128.976153.30822.951-76.324
Cash At End Of Period 402.882526.756319.443718.331,102.661545.5461,000.1411,217.387960.788661.785720.321940.9591,095.3791,315.156186.1832.8719.921